Report Highlights
Companion Diagnostics Market
According to Verified Market Research, Global Companion Diagnostics Market was valued at USD 2.98 Billion in 2018 and is projected to reach USD 9.51 Billion by 2026, growing at a CAGR of 15.59 % from 2019 to 2026.
Global Companion Diagnostics Market Outlook
Companion diagnostic will continue to increase in some applications to disease areas. The commercial success of drugs depends on the companion diagnostic. The increasing burden of disease and economic incentives for drug development are the two primary factors driving growth. Companion diagnostics reduces development time and Rx development costs and results in more favorable reimbursement by illustrating comparative effectiveness. In collaboration with pharmaceutical companies, the market is undergoing a remarkable change by developing and identifying the diagnostics to target patients. Approval and commercialization of any drug are challenging, before preferring any medicine or drug to humans it experiments on the animal to analyses its productive or positive as well as negative effects which further helps the researcher whether the drug is suitable for a disorder and human use. However, increasing development costs is restraining the growth of the market.
Global Companion Diagnostics Market Competitive Landscape
The Global Companion Diagnostics Market study report will provide a valuable insight with an emphasis on global market including some of the major players such as F. Hoffmann-La Roche AG, Agilent Technologies, Inc., QIAGEN N.V., Abbott Laboratories, Inc., Almac Group, Danaher Corporation, Illumina Inc., Biomrieux SA, Myriad Genetics, Inc., and Sysmex Corporation.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.
Similar Reports from Verified Market Research
Global Companion Diagnostics Market
The Global Companion Diagnostics Market was valued at USD 2.03 billion in 2016 and is projected to reach USD 10.30 billion by 2025, growing at a CAGR of 19.78% from 2017 to 2025.
A companion diagnostic is a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a ...
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More